Safety and Efficacy of Intrapleural Tissue Plasminogen Activator and DNase during Extended Use in Complicated Pleural Space Infections
The use of intrapleural therapy with tissue plasminogen activator and DNase improves outcomes in patients with complicated pleural space infections. However, little data exists for the use of combination intrapleural therapy after the initial dosing period of six doses. We sought to describe the saf...
Saved in:
| Main Authors: | Jason R. McClune, Candice L. Wilshire, Jed A. Gorden, Brian E. Louie, Alexander S. Farviar, Michael J. Stefanski, Eric Vallieres, Ralph W. Aye, Christopher R. Gilbert |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/2016/9796768 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients
by: Najib M Rahman, et al.
Published: (2019-10-01) -
A Retrospective Cohort Study Evaluating the Safety and Efficacy of Sequential versus Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection
by: Ken Junyang Goh, et al.
Published: (2023-01-01) -
Intrapleural use of urokinase and DNase in pleural infections managed with repeated thoracentesis: A comparative cohort study.
by: David Luque Paz, et al.
Published: (2021-01-01) -
Intrapleural tissue plasminogen activator and deoxyribonuclease in complex pleural effusion and empyema, clinical outcomes, and predictors
by: Yub Raj Sedhai, et al.
Published: (2025-05-01) -
Electronic Medical Record Inaccuracies: Multicenter Analysis of Challenges with Modified Lung Cancer Screening Criteria
by: Candice L. Wilshire, et al.
Published: (2020-01-01)